December 28, 1992, marked a new era for Migraine sufferers with FDA approval of injectable Imitrex (sumatriptan). Imitrex was the first Migraine abortive triptan medication, a class of medications that many Migraineurs would come to call “miracle drugs.” Imitrex tablets were approved by the FDA in 1995. Since then, six more triptans have entered the market – Maxalt, Zomig, Amerge, Axert, Frova, and Relpax.
Although triptans are a marked improvement over previous treatment options,...
Read moreWe frequently discuss that it's important for our doctors to know about any over-the-counter (OTC) medications we take for Migraines and... Read more »
Do you ever wonder how clinical trials for Migraine medications are designed and set up? When we stop and think about it, without some kind... Read more »
Phase III clinical trials for Levadex, a new Migraine abortive medication are progressing well. Levadex, from MAP Pharmaceuticals, has... Read more »
The FDA has approved a new prescription medication for the acute treatment of Migraine attacks, Cambia, developed by Kowa Pharmaceuticals... Read more »
The FDA has issued new warnings about Topamax (topiramate) a medication sometimes used for Migraine and headache prevention. New... Read more »
"We have really great Migraine-specific medications available, and they're not being prescribed to people who could benefit from them… Often,... Read more »
Phase II study data on MK-0974, an investigational oral calcitonin gene-related peptide (CGRP) receptor antagonist showed:MK-0974 significantly... Read more »
Scientists say they may have found a new "target" for future migraine medicines. New research published in the medical journal The Lancet suggest... Read more »
Have you purchased or considered purchasing Migraine or other medications online, from a site that does not require you to have a prescription? If... Read more »
Information presented at the 61st Annual Meeting of the American Academy of Neurology (April, 2009) indicates that glutamate receptors may play a... Read more »